Global Oncology Academy

The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.

Episodes 1-16 of 93

- David R. Gandara, MD
  Peer
0
Project Oncology®
Emerging Research on Non-Small Cell Lung Cancer from ASCO 2021
Emerging Research on Non-Small Cell Lung Cancer from ASCO 2021
Emerging Research on Non-Small Cell Lung Cancer from ASCO 2021
0
Project Oncology®
How Structural Racism Impacts Cancer Disparities: Takeaways from ASCO 2021
How Structural Racism Impacts Cancer Disparities: Takeaways from ASCO 2021
How Structural Racism Impacts Cancer Disparities: Takeaways from ASCO 2021
0
Project Oncology®
Barriers & Facilitators to Telemedicine: Lessons Learned from ASCO 2021
Barriers & Facilitators to Telemedicine: Lessons Learned from ASCO 2021
Barriers & Facilitators to Telemedicine: Lessons Learned from ASCO 2021
0
Project Oncology®
How Social Determinants Impact Cancer Outcomes: Insights from ASCO 2021
How Social Determinants Impact Cancer Outcomes: Insights from ASCO 2021
How Social Determinants Impact Cancer Outcomes: Insights from ASCO 2021
0
Project Oncology®
Equality in Care for All Women: Addressing Disparities in Gynecologic Malignancies at ASCO 2021
Equality in Care for All Women: Addressing Disparities in Gynecologic Malignancies at ASCO 2021
Equality in Care for All Women: Addressing Disparities in Gynecologic Maligna...
0
Project Oncology®
Recapping the ASCO 2021 Annual Meeting Opening Session & Presidential Address
Recapping the ASCO 2021 Annual Meeting Opening Session & Presidential Address
Recapping the ASCO 2021 Annual Meeting Opening Session & Presidential Add...
0
Project Oncology®
Addressing Disparities in Cancer: Novel Initiatives from ASCO 2021
Addressing Disparities in Cancer: Novel Initiatives from ASCO 2021
Addressing Disparities in Cancer: Novel Initiatives from ASCO 2021
- Edward S. Kim, MD
  Peer
0
Closing the Gaps in NSCLC
Understanding the Importance of RET Mutation as a Primary Oncogenic Driver
Understanding the Importance of RET Mutation as a Primary Oncogenic Driver
Understanding the Importance of RET Mutation as a Primary Oncogenic Driver
- Paul P. Doghramji, MD, FAAFP
  Peer
- Edward S. Kim, MD
  Peer
1
Closing the Gaps in NSCLC
Creating Targeted Treatment Pathways Driven by Genomic Makeup & Cancer Type
Creating Targeted Treatment Pathways Driven by Genomic Makeup & Cancer Type
Creating Targeted Treatment Pathways Driven by Genomic Makeup & Cancer Type
- Stephen Liu, MD
  Peer
1
Closing the Gaps in NSCLC
How Immune Checkpoint Inhibitors Changed the Therapeutic Landscape for NSCLC
How Immune Checkpoint Inhibitors Changed the Therapeutic Landscape for NSCLC
How Immune Checkpoint Inhibitors Changed the Therapeutic Landscape for NSCLC
- Michael R. Shafique, MD
  Peer
0
Closing the Gaps in NSCLC
Keys to Successful Maintenance Therapy for Advanced NSCLC
Keys to Successful Maintenance Therapy for Advanced NSCLC
Keys to Successful Maintenance Therapy for Advanced NSCLC
- Michael R. Shafique, MD
  Peer
0
Closing the Gaps in NSCLC
An Oncologist’s Priorities for Managing Adverse Events in NSCLC Care
An Oncologist’s Priorities for Managing Adverse Events in NSCLC Care
An Oncologist’s Priorities for Managing Adverse Events in NSCLC Care
- Jennifer Caudle, DO
  Peer
- Stephen Liu, MD
  Peer
2
Closing the Gaps in NSCLC
Reviewing First-Line Systemic Therapies for Metastatic Non-Small Cell Lung Cancer
Reviewing First-Line Systemic Therapies for Metastatic Non-Small Cell Lung Cancer
Reviewing First-Line Systemic Therapies for Metastatic Non-Small Cell Lung Ca...
- Paul Doghramji, MD
  Peer
- Tony Y. Hu, PhD
  Peer
0
Closing the Gaps in NSCLC
Current & Future Innovations in Lung Cancer Detection
Current & Future Innovations in Lung Cancer Detection
Current & Future Innovations in Lung Cancer Detection
- Paul Doghramji, MD
  Peer
- Tony Y. Hu, PhD
  Peer
0
Closing the Gaps in NSCLC
Investigating a Potential Serum Biomarker for Lung Cancer
Investigating a Potential Serum Biomarker for Lung Cancer
Investigating a Potential Serum Biomarker for Lung Cancer
- Amit Bobby Mahajan, MD, FCCP, DAABIP
  Peer
0
Closing the Gaps in NSCLC
NSCLC State of the Union: Where We Are & Where We're Going
NSCLC State of the Union: Where We Are & Where We're Going
NSCLC State of the Union: Where We Are & Where We're Going